Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

NCT01670266 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension (OHT)
Mild Open Angle-glaucoma (OAG)

Interventions

DRUG: ONO-9054
DRUG: Placebo

Sponsor

Ono Pharma USA Inc